The Elderly Simulation Experience, forms part of a two-day workshop designed by Eisai to provide their staff with a deeper understanding of the experiences of elderly patients.
The staff taking part come from across Europe and are responsible for promoting Eisai’s “Human Health Care” (hhc) mission, which encourages staff to think from the perspective of patients and their families, and so increase the benefits health care provides.
Eisai is committed to developing and providing medicines that are founded on an understanding of directly experiencing the challenges faced by patients. “We hope this simulation of how it feels to be older will help enhance our understanding and empathy for patients – and therefore help us in our work to develop better medicines” said Chihiro Takayama, Executive Director of the Knowledge Creation Department at Eisai Co. Ltd in Japan.
The elements of the simulation to experience “old age” include:•Earplugs
For the purposes of this week’s workshop, the facilities in the room and technology provided by Eisai will be used to create an experience of what it would be like to have failing vision and hearing and restricted movement – all inevitable consequences of ageing.
Before going on tours of a local elderly care home and a school for children with special needs, the Eisai team will be shown the facilities in HICESC, which provides training for healthcare practitioners using life-like manikins.
It houses a family of seven patient simulators, two SimMen, SimMidwife, SimChild, SimBaby and most recently, a Nursing Anne and Nursing Kelly with vital signs, all powered by state-of-the art technology.
Eisai, one of the worlds leading pharmaceutical companies, is building a new “European Knowledge Centre” on the Hatfield Business Park which will bring together teams from Research and Development, Manufacturing and Sales and Marketing functions.
“Eisai, a key employer in the local area, has been a major supporter of our new facility,” said Professor Eeva Leinonen, Deputy Vice-Chancellor at the University. “The Eisai Community Room and the research carried out there will allow us to continue to save and enhance lives through providing life-saving skills for healthcare students.”
Emma Roberts | alfa
Hepatitis: liver failure attributable to compromised blood supply
19.12.2018 | Technische Universität München
Collagen nanofibrils in mammalian tissues get stronger with exercise
14.12.2018 | University of Illinois College of Engineering
Different eras of civilization are defined by the discovery of new materials, as new materials drive new capabilities. And yet, identifying the best material...
Researchers from the University of Basel have reported a new method that allows the physical state of just a few atoms or molecules within a network to be controlled. It is based on the spontaneous self-organization of molecules into extensive networks with pores about one nanometer in size. In the journal ‘small’, the physicists reported on their investigations, which could be of particular importance for the development of new storage devices.
Around the world, researchers are attempting to shrink data storage devices to achieve as large a storage capacity in as small a space as possible. In almost...
The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.
Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...
What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
12.12.2018 | Event News
10.12.2018 | Event News
06.12.2018 | Event News
19.12.2018 | Materials Sciences
19.12.2018 | Materials Sciences
19.12.2018 | Life Sciences